Maturity‐Onset Diabetes of the Young (MODY) With HNF1B p.Glu105Lys Mutation Achieving Significant Insulin Reduction on Tirzepatide: A Case Report

ABSTRACT This report describes the first case of maturity‐onset diabetes in young (MODY) with HNF1B mutation started administration of the dual glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1 receptor agonist, tirzepatide. A 26‐year‐old female with a 15‐year history of diabe...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Mihiro Sue, Mayu Watanabe, Ayumi Inoue, Akihiro Katayama, Sanae Teshigawara, Yuichi Matsushita, Masaya Takeda, Izumi Iseda, Jun Eguchi, Kazuyuki Hida
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2025-02-01
coleção:	Clinical Case Reports
Assuntos:	glucagon‐like peptide‐1 (GLP‐1) glucose‐dependent insulinotropic polypeptide (GIP) maturity‐onset diabetes in young (MODY) tirzepatide
Acesso em linha:	https://doi.org/10.1002/ccr3.70173
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!